See other companies on Welcome to the Jungle
Sava
Continuous glucose monitors
- 21-100 employees
- Healthcare
- B2C
- B2B
- Personal health
- Analytics
- Internet of Things
- Mobile
- Wellbeing
- Barbican, London, UK
Jump to section
Company mission
To transform healthcare from a curative to a preventative system.
Few candidates hear
back within 2 weeks
Our take
Continuous glucose monitors are devices that attach to a user's arm to monitor blood sugar levels. Having been in use for some years now, the next generation of health tech startups is looking to improve upon the hardware. Sava is one of these companies, utilising deep tech data analysis to provide everyday health insights previously reserved for the laboratory.
Covering a range of conditions, Sava analyses not only glucose levels but other molecules such as cortisol, sodium and urea. The device is connected to a mobile app that provides users with the data they need to stay informed on their health.
Whilst CGMs have been on the market for some time, Sava is positioning itself as the next generation of health monitors. It's emerging onto the market at a time when investment is rife for the wearable health tech industry. Plus, its impressive seed funding rounds have provided it with a springboard to expand its manufacturing capabilities and take its product through clinical trial stages.
Freddie
Company Specialist at Welcome to the Jungle
Funding (1 round)
Jun 2024
$8m
SEED
Total funding: $8m
This company has top investors
Leadership
Renato Circi
(Co-CEO)Previously Co-Founder at Caura and worked in Business Development at The Ortus Club.
Rafaël Michali
(Co-CEO)Previously Co-Founder at Caura.